In re Lipitor (Atorvastatin Calcium) Marketing, Sales Practices & Products Liability Litigation
District Court, D. South Carolina
1Opinion of the Court
*455CASE MANAGEMENT ORDER NO. 100
This Order relates to the cases listed in Appendix 1
Richard Mark Gergel, United States District Court Judge
Before the Court is Defendant’s Omnibus Motion for Summary Judgment, (Dkt. *456No. 1564).1 For the reasons stated below, the motion is GRANTED IN PART.2
I. Background
A. Procedural History
On February 18, 2014, the Judicial Panel on Multidistrict Ligation created this MDL, centralizing cases where female plaintiffs “allege that they have developed type 2 diabetes as a result of taking Pfizer’s cholesterol-lowering drug Lipitor.” (Dkt. No. 1 at 1). Plaintiffs allege…
2Cases cited147 opinions
- Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
- Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
- Lexecon Inc. v. Milberg Weiss Bershad Hynes & LerachSupreme Court of the United States · 1998
- Nikitas Amorgianos v. National Railroad Passenger CorporationCourt of Appeals for the Second Circuit · 2002
- Westberry v. Gislaved Gummi ABCourt of Appeals for the Fourth Circuit · 1999
142 more not listed; retrieve them via the Exa API.
3Cited by18 opinions
- Lipitor (Atorvastatin Calcium) Mktg. v. Pfizer, Inc.Court of Appeals for the Fourth Circuit · 2018
- Cynthia Madej v. Jeff MaidenCourt of Appeals for the Sixth Circuit · 2020
- Ashley Bard v. Brown Cty., OhioCourt of Appeals for the Sixth Circuit · 2020
- In re Onglyza (Saxagliptin) and Kombiglyze (Saxagliptin and Metformin) Prods. Liability Litig.Court of Appeals for the Sixth Circuit · 2024
- In re Mirena Ius Levonorgestrel-Related Prods. Liab. Litig. (No. II)District Court, S.D. Illinois · 2019
13 more not listed; retrieve them via the Exa API.